Hexarelin
Tested in peopleIt has been tested in people, but it is not an approved medicine. The studies are usually small.
Also called Examorelin / EP-23905
Studied for raising growth hormone. Also looked at for effects on the heart.
Can a doctor prescribe this?
No. Pharmacies are not on record as being allowed to make this into a medicine.
The FDA has not approved this as a medicine.
Never approved anywhere. Not on the 503A list.
Official status: Not on the 503A bulks list. Checked 2026-08-04.
Lab suppliers we list: 8
Doses used in research
Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.
In animal studies
These are doses given to animals, usually per kilogram of body weight. They do not convert directly to a human dose.
200 mcg/kg
mice · twice per day
Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation.Microvascular research · 2022
“The present study determined the effect of hexarelin administration (200 μg/kg twice per day) in a mouse model of elastase-induced abdominal aortic aneurysm.”
5 mg/mL
rats ·
Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats.Acta pharmaceutica Sinica. B · 2021
“These luminal compositions included two paracellular permeation enhancers, chitosan (5 mg/mL) and ethylenediaminetetraacetate (EDTA, 1 and 5 mg/mL), as well as low luminal tonicity (100 mOsm) with or without lidocaine.”
10.56 mcg/day
mice · into a vein · for 3-4 weeks
Stimulation of endogenous pulsatile growth hormone secretion by activation of growth hormone secretagogue receptor reduces the fat accumulation and improves the insulin sensitivity in obese mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
“Male melanocortin 4 receptor knockout mice (MC4RKO) were pair-fed and received continuous hexarelin (10.56 μg/day) or vehicle infusion by an osmotic pump for 3-4 weeks.”
See source wording
rats ·
Ghrelin receptor agonist hexarelin attenuates antinociceptive tolerance to morphine in rats.Canadian journal of physiology and pharmacology · 2021
“A total of 104 Wistar albino male adult rats (weighing approximately 220-240 g) were used in the experiments.”
0.3 mg/kg/day
mice · for 21 days
Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia-reperfusion.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
“Myocardial ischemia was induced by transient ligation of the left descending coronary artery (tLAD) in C57BL/6 J mice followed by HEX (0.3 mg/kg/day; n = 20) or vehicle (VEH) (n = 18) administration for 21 days, first administered immediately prior-to reperfusion.”
100 mcg/kg
mice · for 3 months
“Mice were treated either with hexarelin (100 μg/kg s.c., q.d.”
100 mcg/kg
rats · under the skin · twice a day · for 30 days
Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart failure in ratsTurkish journal of medical sciences · 2019
“The rats were treated with subcutaneous injection of hexarelin (100 μg/kg) in the treatment group or saline in the other groups twice a day for 30 days.”
See source wording
rats · daily
Enhanced Pulsatile Growth Hormone Secretion and Altered Metabolic Hormones by in Vivo Hexarelin Treatment in Streptozotocin-Induced Diabetic Rats.International journal of molecular sciences · 2018
“Thus, we aim to investigate the effect of hexarelin, a synthetic GH secretagogue (GHS), on GH secretion in streptozotocin (STZ, 65 mg/kg)-induced diabetic rats.”
See source wording
rats · daily · for 2 weeks
Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin-induced diabetic rats.Physiological reports · 2018
“Streptozotocin (STZ, 65 mg/kg)-induced diabetic rat model was employed with vehicle injection group as control.”
See source wording
rats · under the skin · twice daily · for 7 days
The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.International heart journal · 2017
“The rats were then treated subcutaneously twice daily with hexarelin [100 μg/kg·day], ghrelin [400 μg/ kg·day], or saline for 7 days.”
200 mcg/kg
mice · another route · twice daily · for 12 days
Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice.Endocrinology · 2017
“In this study, the effects of twice daily intraperitoneal injections of hexarelin (200 μg/kg body weight) were examined in nonobese insulin-resistant MKR mice and corresponding wild-type FVB mice for 12 days.”
See source wording
rats · by mouth
The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin.Pharmaceutics · 2020
“The objective of this single-pass perfusion study in rat was to investigate the effect of SDS at 5 mg/mL and of caprate administered at different luminal concentrations (5, 10, and 20 mg/mL) and pH (6.5 and 7.4).”
100 mcg/kg/day
rats · for 7 days
Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway.European journal of medical research · 2023
“In the I/R-induced AKI model, rats were pretreated with Hexarelin at 100 μg/kg/d for 7 days before being sacrificed 24 h post-IRI.”
- Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator.
Animal study, rats or mice
Frontiers in pharmacology · 2024
- Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation.
Animal study, rats or mice
Microvascular research · 2022
- Using Synchrotron Radiation Imaging Techniques to Elucidate the Actions of Hexarelin in the Heart of Small Animal Models.
Animal study, rats or mice
Frontiers in physiology · 2021
- Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats.
Animal study, rats or mice
Acta pharmaceutica Sinica. B · 2021
- Stimulation of endogenous pulsatile growth hormone secretion by activation of growth hormone secretagogue receptor reduces the fat accumulation and improves the insulin sensitivity in obese mice.
Animal study, rats or mice
FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
- Ghrelin receptor agonist hexarelin attenuates antinociceptive tolerance to morphine in rats.
Animal study, rats or mice
Canadian journal of physiology and pharmacology · 2021
- Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia-reperfusion.
Animal study, rats or mice
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
- Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE<sup>-/-</sup> mice.
Animal study, rats or mice
Peptides · 2019
- Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart failure in rats
Animal study, rats or mice
Turkish journal of medical sciences · 2019
- Enhanced Pulsatile Growth Hormone Secretion and Altered Metabolic Hormones by in Vivo Hexarelin Treatment in Streptozotocin-Induced Diabetic Rats.
Animal study, rats or mice
International journal of molecular sciences · 2018
- Zebrafish (Danio rerio) water tank model for the investigation of drug metabolism: Progress, outlook, and challenges.
Animal study, rats or mice
Drug testing and analysis · 2018
- Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin-induced diabetic rats.
Animal study, rats or mice
Physiological reports · 2018
- The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.
Animal study, rats or mice
International heart journal · 2017
- Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice.
Animal study, rats or mice
Endocrinology · 2017
- Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia.
Animal study, rats or mice
Scientific reports · 2017
- Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein.
Lab dish study
International journal of molecular sciences · 2023
- Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide-Induced Apoptotic Toxicity.
Lab dish study
Pharmaceuticals (Basel, Switzerland) · 2021
- Hexarelin exerts neuroprotective and antioxidant effects against hydrogen peroxide-induced toxicity through the modulation of MAPK and PI3K/Akt patways in Neuro-2A cells
Lab dish study
Journal not recorded · 2020
- The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin.
Lab dish study
Pharmaceutics · 2020
- Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia.
Lab dish study
Journal of cachexia, sarcopenia and muscle · 2017
- Hexarelin promotes the survival of retinal ganglion cells after optic nerve transection.
Indian journal of pharmacology · 2026
- Revealing the interaction between peptide drugs and permeation enhancers in the presence of intestinal bile salts.
Nanoscale · 2023
- Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury.
Drug target insights · 2021
- The CD36-PPARγ Pathway in Metabolic Disorders.
International journal of molecular sciences · 2018
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.
Review of earlier work
Frontiers in endocrinology · 2026
- Identification of alexamorelin consumption biomarkers using human hepatocyte incubations and high-resolution mass spectrometry.
Review of earlier work
Journal of analytical toxicology · 2025
- Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway.
Review of earlier work
European journal of medical research · 2023
- Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy <i>via</i> the regulation of autophagy.
Review of earlier work
Die Pharmazie · 2019